Together Senior Health (Together), a Linus Health company, announces the release of a new report published by Milliman, a leading actuarial firm, that evaluates the accuracy of Together's Risk of ...
Safety concerns Keros observed in a Phase 2 trial triggered a stock selloff for what had been one of the sector’s most successful initial public offerings of the last four years, according to ...
Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental ...
Commissions do not affect our editors' opinions or evaluations. Urgent care centers offer a convenient option for non-life threatening injuries and illnesses, such as cuts and bruises, rashes ...
On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-U.S. (IAS-U.S.) has published new international guidelines for the treatment and ...
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers Liver transplantation (LT) ...
was the “fairly technical question” of “whether or not the WPATH standards of care adhere to current best practices for the development and reporting of clinical practice guidelines.
The issue that HERC had been wrestling with internally, he said, was the “fairly technical question” of “whether or not the WPATH standards of care adhere to current best practices for the development ...
Draft recommendations, by a committee of scientists advising the U.S. government on its next round of dietary guidelines, were first discussed in October.
coordinating care for Medicare beneficiaries to reduce costs and boost care quality. Milliman MedInsight, an innovator in healthcare data management, stands as a premier platform for value-based ...
Here are eight insights they shared that you need to know. The HealthLeaders AI in Clinical Care Mastermind program reached a milestone today, with healthcare provider executives discussing key ...